Phase 2/3 Clinical Results Of Il-15rafc Superagonist N-803 With Bcg In Bcg-Unresponsive Non-Muscle Invasive Bladder Cancer (Nmibc) Carcinoma In-Situ (Cis) Patients.
JOURNAL OF UROLOGY(2021)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF UROLOGY(2021)